Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aprea Therapeutics

Clinical trials sponsored by Aprea Therapeutics, explained in plain language.

Aprea Therapeutics APRE NASDAQ

A clinical-stage biopharmaceutical company developing cancer therapies targeting p53 mutations.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New pill targets tough cancers in early human trial

Disease control Completed

This early-phase trial is testing an oral drug called ATRN-119 in 132 people with advanced solid tumors that have specific DNA repair mutations. The main goals are to check safety, how the drug moves through the body, and whether it can shrink tumors. Participants must be able to…

Phase: PHASE1, PHASE2 • Sponsor: Aprea Therapeutics • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC